tiprankstipranks
Trending News
More News >
Eurobio-Scientific SA (FR:ALERS)
:ALERS
France Market
Advertisement

Eurobio-Scientific SA (ALERS) Ratios

Compare
1 Followers

Eurobio-Scientific SA Ratios

FR:ALERS's free cash flow for Q4 2024 was €0.45. For the 2024 fiscal year, FR:ALERS's free cash flow was decreased by € and operating cash flow was €0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.03 2.72 2.59 4.79 2.82
Quick Ratio
1.42 2.32 2.21 4.34 2.55
Cash Ratio
0.49 0.93 0.83 2.57 1.36
Solvency Ratio
0.14 0.13 0.22 1.40 1.25
Operating Cash Flow Ratio
0.52 0.51 0.73 1.81 1.13
Short-Term Operating Cash Flow Coverage
31.83 2.02 3.05 17.81 3.90
Net Current Asset Value
€ 11.27M€ 2.75M€ -9.38M€ 123.95M€ 70.76M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.32 0.34 0.07 0.17
Debt-to-Equity Ratio
0.19 0.58 0.66 0.10 0.28
Debt-to-Capital Ratio
0.16 0.37 0.40 0.09 0.22
Long-Term Debt-to-Capital Ratio
0.13 0.32 0.35 0.04 0.09
Financial Leverage Ratio
1.44 1.81 1.92 1.31 1.61
Debt Service Coverage Ratio
6.04 1.27 2.38 16.67 5.58
Interest Coverage Ratio
7.18 2.33 24.10 158.21 131.20
Debt to Market Cap
0.11 0.52 0.52 0.04 0.13
Interest Debt Per Share
3.53 9.48 11.24 1.49 2.71
Net Debt to EBITDA
0.62 2.12 1.63 -0.97 -0.40
Profitability Margins
Gross Profit Margin
45.06%44.00%42.62%52.75%55.92%
EBIT Margin
8.44%8.68%20.29%38.85%43.00%
EBITDA Margin
12.69%18.79%26.53%43.11%46.90%
Operating Profit Margin
9.97%7.76%20.34%38.97%43.00%
Pretax Profit Margin
4.06%5.34%19.45%38.61%42.83%
Net Profit Margin
2.58%3.70%16.34%32.78%38.91%
Continuous Operations Profit Margin
2.58%3.70%16.34%32.78%38.91%
Net Income Per EBT
63.49%69.30%84.01%84.90%90.84%
EBT Per EBIT
40.73%68.80%95.63%99.06%99.60%
Return on Assets (ROA)
1.56%1.53%7.55%28.94%42.65%
Return on Equity (ROE)
2.24%2.76%14.47%37.86%68.61%
Return on Capital Employed (ROCE)
7.26%3.85%11.36%41.58%65.33%
Return on Invested Capital (ROIC)
4.55%2.52%9.04%34.27%52.79%
Return on Tangible Assets
3.86%2.96%41.82%35.77%58.81%
Earnings Yield
1.56%2.64%11.98%20.73%38.68%
Efficiency Ratios
Receivables Turnover
4.68 4.62 3.81 4.21 3.69
Payables Turnover
5.56 4.35 4.73 5.20 5.85
Inventory Turnover
3.17 3.41 4.04 5.36 6.44
Fixed Asset Turnover
12.15 10.62 12.05 18.38 19.04
Asset Turnover
0.60 0.41 0.46 0.88 1.10
Working Capital Turnover Ratio
2.25 1.43 1.34 1.65 3.94
Cash Conversion Cycle
127.72 102.11 108.89 84.68 93.23
Days of Sales Outstanding
78.04 78.99 95.88 86.67 98.98
Days of Inventory Outstanding
115.31 107.01 90.26 68.14 56.68
Days of Payables Outstanding
65.63 83.89 77.25 70.13 62.43
Operating Cycle
193.35 186.00 186.14 154.81 155.66
Cash Flow Ratios
Operating Cash Flow Per Share
2.25 2.40 4.09 6.03 4.85
Free Cash Flow Per Share
1.95 2.04 3.82 5.86 4.64
CapEx Per Share
0.30 0.36 0.28 0.17 0.20
Free Cash Flow to Operating Cash Flow
0.86 0.85 0.93 0.97 0.96
Dividend Paid and CapEx Coverage Ratio
7.40 6.60 14.77 35.44 23.64
Capital Expenditure Coverage Ratio
7.40 6.60 14.77 35.44 23.64
Operating Cash Flow Coverage Ratio
0.68 0.26 0.37 4.18 1.83
Operating Cash Flow to Sales Ratio
0.15 0.20 0.27 0.35 0.29
Free Cash Flow Yield
7.96%12.39%18.74%21.78%27.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
64.18 37.92 8.35 4.82 2.59
Price-to-Sales (P/S) Ratio
1.62 1.40 1.36 1.58 1.01
Price-to-Book (P/B) Ratio
1.44 1.05 1.21 1.83 1.77
Price-to-Free Cash Flow (P/FCF) Ratio
12.56 8.07 5.34 4.59 3.65
Price-to-Operating Cash Flow Ratio
11.13 6.85 4.97 4.46 3.50
Price-to-Earnings Growth (PEG) Ratio
-1.53 -0.46 -0.15 -0.32 <0.01
Price-to-Fair Value
1.44 1.05 1.21 1.83 1.77
Enterprise Value Multiple
13.36 9.59 6.77 2.70 1.75
Enterprise Value
262.92M 235.38M 274.28M 214.78M 154.56M
EV to EBITDA
13.36 9.59 6.77 2.70 1.75
EV to Sales
1.70 1.80 1.80 1.16 0.82
EV to Free Cash Flow
13.17 10.36 7.03 3.38 2.97
EV to Operating Cash Flow
11.39 8.79 6.55 3.28 2.85
Tangible Book Value Per Share
2.47 1.98 -9.60 11.09 5.40
Shareholders’ Equity Per Share
17.45 15.71 16.86 14.74 9.56
Tax and Other Ratios
Effective Tax Rate
0.37 0.31 0.16 0.15 0.09
Revenue Per Share
15.13 11.71 14.93 17.03 16.85
Net Income Per Share
0.39 0.43 2.44 5.58 6.56
Tax Burden
0.63 0.69 0.84 0.85 0.91
Interest Burden
0.48 0.62 0.96 0.99 1.00
Research & Development to Revenue
0.04 0.07 0.02 0.02 0.01
SG&A to Revenue
0.05 0.11 0.07 0.04 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
3.47 5.54 1.68 1.08 0.74
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis